Skip to main content
Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
1.850
+0.050 (2.78%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Serina Therapeutics Revenue

In the year 2025, Serina Therapeutics had annual revenue of $130.00K with 132.14% growth.

Revenue (ttm)
$130.00K
Revenue Growth
+132.14%
P/S Ratio
171.45
Revenue / Employee
$10,000
Employees
13
Market Cap
22.78M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025130.00K74.00K132.14%
Dec 31, 202456.00K-3.10M-98.22%
Dec 31, 20233.15M2.56M433.05%
Dec 31, 2022591.50K-2.87M-82.93%
Dec 31, 20213.46M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Barinthus Biotherapeutics 14.97M
Curis 9.44M
Marker Therapeutics 3.55M
OSR Holdings 2.91M
ABVC BioPharma 797.92K
Vistagen Therapeutics 789.00K
Lexaria Bioscience 368.00K
Revenue Rankings

SER News

More News